Attached files
| file | filename |
|---|---|
| 10-K - FORM 10-K - Panbela Therapeutics, Inc. | snbp20171231_10k.htm |
| EX-32.2 - EXHIBIT 32.2 - Panbela Therapeutics, Inc. | ex_108272.htm |
| EX-32.1 - EXHIBIT 32.1 - Panbela Therapeutics, Inc. | ex_108271.htm |
| EX-31.2 - EXHIBIT 31.2 - Panbela Therapeutics, Inc. | ex_108270.htm |
| EX-31.1 - EXHIBIT 31.1 - Panbela Therapeutics, Inc. | ex_108269.htm |
| EX-24.1 - EXHIBIT 24.1 - Panbela Therapeutics, Inc. | ex_108063.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 (No. 333-213610) of our report dated March 21, 2018 included in this Annual Report on Form 10-K of Sun Biopharma, Inc. and Subsidiary (the “Company”), relating to the consolidated balance sheets of the Company as of December 31, 2017 and 2016, and the related consolidated statements of operations and comprehensive loss, stockholders’ deficit, and cash flows for the years then ended.
/s/ Cherry Bekaert
Tampa, Florida
March 21, 2018